{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:49:47Z","timestamp":1791535787182,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K08 EY0231186"],"award-info":[{"award-number":["1K08 EY0231186"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 EY029985"],"award-info":[{"award-number":["1R01 EY029985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K08 EY026650"],"award-info":[{"award-number":["1K08 EY026650"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY010572"],"award-info":[{"award-number":["P30EY010572"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajo.2022.02.013","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T05:10:24Z","timestamp":1646370624000},"page":"285-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Three\u2010Year Safety Results of SAR422459 (EIAV\u2010ABCA4) Gene Therapy in Patients With ABCA4\u2010Associated Stargardt Disease: An Open\u2010Label Dose\u2010Escalation Phase I\/IIa Clinical Trial, Cohorts 1\u20105"],"prefix":"10.1016","volume":"240","author":[{"given":"Maria A.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Erker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-5309","authenticated-orcid":false,"given":"Isabelle","family":"Audo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-4072","authenticated-orcid":false,"given":"Dongseok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saddek","family":"Mohand-Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-5887","authenticated-orcid":false,"given":"Kastytis","family":"Sestakauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-622X","authenticated-orcid":false,"given":"Patrick","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Appelqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Krahmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-0123","authenticated-orcid":false,"given":"Caroline","family":"S\u00e9gaut-Pr\u00e9vost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-9275","authenticated-orcid":false,"given":"Brandon J.","family":"Lujan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambar","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-2161","authenticated-orcid":false,"given":"Elvira N.","family":"Chegarnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Steinkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristy","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-279X","authenticated-orcid":false,"given":"Mariana Matioli","family":"da Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Barale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ayelo-Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-9030","authenticated-orcid":false,"given":"Andreas","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Weleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Pennesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4831-1153","authenticated-orcid":false,"given":"Jos\u00e9 Alain","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2294-0979","authenticated-orcid":false,"given":"Paul","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0001","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng0397-236","article-title":"A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy","volume":"15","author":"Allikmets","year":"1997","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ajo.2022.02.013_bib0002","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.ajo.2022.02.013_bib0003","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.plipres.2010.07.002","article-title":"Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration","volume":"49","author":"Molday","year":"2010","journal-title":"Prog Lipid Res"},{"issue":"2","key":"10.1016\/j.ajo.2022.02.013_bib0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/geno.1999.5896","article-title":"The ABCR gene in recessive and dominant Stargardt diseases: a genetic pathway in macular degeneration","volume":"60","author":"Zhang","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.ajo.2022.02.013_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preteyeres.2013.11.001","article-title":"Macular dystrophies mimicking age-related macular degeneration","volume":"39","author":"Saksens","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2022.02.013_bib0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13816810802695550","article-title":"Natural history of phenotypic changes in Stargardt's macular dystrophy","volume":"30","author":"Walia","year":"2009","journal-title":"Ophthalmic Genet"},{"issue":"11","key":"10.1016\/j.ajo.2022.02.013_bib0007","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/eye.2013.176","article-title":"Phenotype\/genotype correlation in a case series of Stargardt's patients identifies novel mutations in the ABCA4 gene","volume":"27","author":"Gemenetzi","year":"2013","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.ajo.2022.02.013_bib0008","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ophtha.2012.01.005","article-title":"Clinical and genetic characteristics of late-onset Stargardt's disease","volume":"119","author":"Westeneng-van Haaften","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2022.02.013_bib0009","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jamaophthalmol.2018.2198","article-title":"Visual acuity change over 24 months and its association with foveal phenotype and genotype in individuals with Stargardt disease: ProgStar study report no. 10","volume":"136","author":"Kong","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2022.02.013_bib0010","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/ijms19082196","article-title":"Expanding the mutation spectrum in ABCA4: sixty novel disease causing variants and their associated phenotype in a large French Stargardt cohort","volume":"19","author":"Nassisi","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ajo.2022.02.013_bib0011","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0161-6420(91)32196-1","article-title":"Delayed rod dark adaptation in patients with Stargardt's disease","volume":"98","author":"Fishman","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.02.013_bib0012","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00918432","article-title":"Color vision in Stargardt's disease","volume":"16","author":"M\u00e4ntyj\u00e4rvi","year":"1992","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.013_bib0013","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1167\/iovs.10-6538","article-title":"Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease","volume":"52","author":"Chen","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2022.02.013_bib0014","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1167\/iovs.11-8182","article-title":"Analysis of the ABCA4 gene by next-generation sequencing","volume":"52","author":"Zernant","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.ajo.2022.02.013_bib0015","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1073\/pnas.1400780111","article-title":"ATP-binding cassette transporter ABCA4 and chemical isomerization protect photoreceptor cells from the toxic accumulation of excess 11-cis-retinal","volume":"111","author":"Quazi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajo.2022.02.013_bib0016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4419-5635-4_8","article-title":"The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease","volume":"703","author":"Tsybovsky","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajo.2022.02.013_bib0017","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000099259","article-title":"Immunosuppressive properties of the pigmented epithelial cells and the subretinal space","volume":"92","author":"Zamiri","year":"2007","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.ajo.2022.02.013_bib0018","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.gt.3301023","article-title":"Stable gene transfer to the nervous system using a non-primate lentiviral vector","volume":"6","author":"Mitrophanous","year":"1999","journal-title":"Gene Ther"},{"issue":"19","key":"10.1016\/j.ajo.2022.02.013_bib0019","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/gt.2008.78","article-title":"Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy","volume":"15","author":"Kong","year":"2008","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.ajo.2022.02.013_bib0020","first-page":"99","volume":"28","author":"Campochiaro","year":"2017","journal-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study. Hum Gene Ther"},{"issue":"6","key":"10.1016\/j.ajo.2022.02.013_bib0021","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1167\/iovs.13-11871","article-title":"Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease","volume":"54","author":"Binley","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2022.02.013_bib0022","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1089\/hum.2012.008","article-title":"Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat((R)), for age-related macular degeneration","volume":"23","author":"Binley","year":"2012","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0023","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archopht.119.3.359","article-title":"Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus","volume":"119","author":"Lois","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2022.02.013_bib0024","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0161-6420(13)38009-9","article-title":"Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.02.013_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.4.2.14","article-title":"VFMA: topographic analysis of sensitivity data full-field static perimetry","volume":"4","author":"Weleber","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"10.1016\/j.ajo.2022.02.013_bib0026","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1167\/iovs.10-6612","article-title":"Quality and reproducibility of retinal thickness measurements in two spectral-domain optical coherence tomography machines","volume":"52","author":"Krebs","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2022.02.013_bib0027","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/bjophthalmol-2015-307035","article-title":"Assessment of estimated retinal atrophy progression in Stargardt macular dystrophy using spectral-domain optical coherence tomography","volume":"100","author":"Strauss","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.013_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10633-017-9580-3","article-title":"International Society for Clinical Electrophysiology of Vision. Erratum to: ISCEV Standard for clinical electro-oculography (2017 update)","volume":"134","author":"Constable","year":"2017","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.02.013_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-017-9573-2","article-title":"International Society for Clinical Electrophysiology of Vision. ISCEV Standard for clinical electro-oculography (2017 update)","volume":"134","author":"Constable","year":"2017","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-007-9053-1","article-title":"ISCEV standard for clinical pattern electroretinography\u20142007 update","volume":"114","author":"Holder","year":"2007","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.02.013_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-011-9296-8","article-title":"ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition)","volume":"124","author":"Hood","year":"2012","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.02.013_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10633-008-9155-4","article-title":"ISCEV Standard for full-field clinical electroretinography (2008 update)","volume":"118","author":"Marmor","year":"2009","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.02.013_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"Erratum to: ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajo.2022.02.013_bib0034","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.5.5.10","article-title":"Test-retest variability of functional and structural parameters in patients with Stargardt disease participating in the SAR422459 gene therapy trial","volume":"5","author":"Parker","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2022.02.013_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2019.02.007","article-title":"Correlation of outer retinal degeneration and choriocapillaris loss in Stargardt disease using en face OCT and OCT angiography","volume":"202","author":"Alabduljalil","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0036","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.8.3.37","article-title":"Reliability of spectral-domain OCT ellipsoid zone area and shape measurements in retinitis pigmentosa","volume":"8","author":"Smith","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"10.1016\/j.ajo.2022.02.013_bib0037","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1364\/BOE.6.003405","article-title":"Pupil tracking optical coherence tomography for precise control of pupil entry position","volume":"6","author":"Carrasco-Zevallos","year":"2015","journal-title":"Biomed Opt Express"},{"issue":"2","key":"10.1016\/j.ajo.2022.02.013_bib0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10633-014-9471-9","article-title":"Multi-center variability of ISCEV standard ERGs in two normal adults","volume":"130","author":"Hamilton","year":"2015","journal-title":"Doc Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2022.02.013_bib0039","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"The Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ajo.2022.02.013_bib0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/13816810.2018.1533027","article-title":"Gene therapy for RPE65-related retinal disease","volume":"39","author":"Miraldi","year":"2018","journal-title":"Ophthalmic Genet"},{"issue":"9","key":"10.1016\/j.ajo.2022.02.013_bib0041","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bjophthalmol-2016-309975","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: clinical features, molecular genetics, and therapeutic interventions","volume":"101","author":"Kumaran","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"10045","key":"10.1016\/j.ajo.2022.02.013_bib0042","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ajo.2022.02.013_bib0043","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ophtha.2016.03.003","article-title":"Results at 2 years after gene therapy for RPE65-deficient Lbere congenital amaurosis and severe early-childhood onset retinal dystrophy","volume":"123","author":"Weleber","year":"2016","journal-title":"Ophthalmology"},{"issue":"21","key":"10.1016\/j.ajo.2022.02.013_bib0044","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2022.02.013_bib0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","article-title":"Safety and long-term efficacy of aav4 gene therapy in patients with rpe65 Lebere congenital amaurosis","volume":"26","author":"Le Meur","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajo.2022.02.013_bib0046","series-title":"Spark Therapeutics Inc. LUXTURNA (voretigene neparvovec-rzyl) [package insert]","year":"2017"},{"key":"10.1016\/j.ajo.2022.02.013_bib0047","article-title":"Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments","volume":"10","author":"Mitsio","year":"2018","journal-title":"Ther Adv Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2022.02.013_bib0048","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/14712598.2018.1484448","article-title":"Choroideremia: molecular mechanisms and development of AAV gene therapy","volume":"18","author":"Patricio","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0049","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17469899.2018.1475232","article-title":"Ocular gene therapy for choroideremia: clinical trials and future perspectives","volume":"13","author":"Xue","year":"2018","journal-title":"Exp Rev Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2022.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ymthe.2017.05.004","article-title":"Optimization of retinal gene therapy for x-linked retinitis pigmentosa due to RPGR mutations","volume":"25","author":"Beltran","year":"2017","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0051","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/21678707.2018.1444476","article-title":"Gene therapy for the treatment of X-linked retinitis pigmentosa","volume":"6","author":"Martinez-Fernandez De La Camara","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"issue":"11","key":"10.1016\/j.ajo.2022.02.013_bib0052","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.ophtha.2017.04.026","article-title":"Visual acuity change over 12 months in the prospective progression of atrophy secondary to Stargardt disease (ProgStar) study: ProgStar report number 6","volume":"124","author":"Kong","year":"2017","journal-title":"Ophthalmology"},{"issue":"47","key":"10.1016\/j.ajo.2022.02.013_bib0053","doi-asserted-by":"crossref","first-page":"E11120","DOI":"10.1073\/pnas.1802519115","article-title":"Expression of ABCA4 in the retinal pigment epithelium and its implications for Stargardt macular degeneration","volume":"115","author":"Lenis","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ajo.2022.02.013_bib0054","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ymthe.2019.11.014","article-title":"The effect of CpG sequences on capsid-specific CD8\u00a0+\u00a0T cell responses to AAV vector gene transfer","volume":"28","author":"Xiang","year":"2020","journal-title":"Mol Ther"},{"issue":"suppl A114","key":"10.1016\/j.ajo.2022.02.013_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.14249","article-title":"Subretinal surgery: functional and histological consequences of entry into the subretinal space","volume":"97","author":"S\u00f8rensen","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2022.02.013_bib0056","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/02713680701199377","article-title":"Effects of subretinal injection of patent blue and trypan blue in rabbits","volume":"32","author":"Maia","year":"2007","journal-title":"Curr Eye Res"},{"issue":"12","key":"10.1016\/j.ajo.2022.02.013_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209996","article-title":"The influence of subretinal injection pressure on the microstructure of the monkey retina","volume":"13","author":"Takahashi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2022.02.013_bib0058","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1167\/iovs.06-0367","article-title":"Eccentric fixation in Stargardt's disease assessed by T\u00fcbingen perimetry","volume":"48","author":"Messias","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:24:36Z","timestamp":1777382676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"alternative-id":["S0002939422000691"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.02.013","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three\u2010Year Safety Results of SAR422459 (EIAV\u2010ABCA4) Gene Therapy in Patients With ABCA4\u2010Associated Stargardt Disease: An Open\u2010Label Dose\u2010Escalation Phase I\/IIa Clinical Trial, Cohorts 1\u20105","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}